THERAMEX
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97583564
- Registration number
- 7233959
- Mark type
- Design + words
- Filed
- 08 Sept 2022
- Published for opposition
- 19 Sept 2023
- Registered
- 05 Dec 2023
- Attorney of record
- Leigh Ann Lindquist
Goods and services
- Class 005 — Pharmaceuticals: Anti-fungal pharmaceutical preparations; Contraceptive preparations; contraceptive sponges; chemical contraceptives; oral contraceptives; Dermatological pharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substances for use in relation to women's health, namely, menopause, osteoporosis, uterine fibroids, endometriosis, adenomyosis, menstrual bleeding disorders, fertility, infertility, assisted reproductive technology, IVF; Pharmaceutical preparations and substances containing steroids; Pharmaceutical preparations and substances containing hormones; Pharmaceutical preparations and substances in the nature of hormone replacement therapy; pharmaceutical preparations and substances for use in relation to reproductive health, namely, contraception, menstrual bleeding disorders, fertility, infertility, fertility enhancement preparations, assisted reproductive technology, IVF, miscarriage; pharmaceutical preparations and substances for use in relation to contraception; pharmaceutical preparations and substances for use in relation to conception, namely, contraception, menstrual bleeding disorders, fertility, infertility, fertility enhancement preparations, assisted reproductive technology, IVF, miscarriage; pharmaceutical preparations and substances for use in relation to fertility; fertility enhancement preparations; pharmaceutical preparations and substances for use in relation to the treatment of infertility; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in gynaecology; pharmaceutical preparations and substances for use in rheumatology; pharmaceutical preparations and substances for use in dermatology; Pharmaceutical preparations for the treatment of menopause; Pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; Pharmaceutical preparations and substances for the treatment of osteoporosis; Pharmaceutical preparations and substances for the alleviation of osteoporosis-related symptoms; Pharmaceutical preparations and substances for the treatment of cartilage disorders; Pharmaceutical preparations and substances for the treatment of bone disorders; Pharmaceutical preparations and substances for the treatment of bone loss; Pharmaceutical preparations and substances for the treatment of arthritis; Pharmaceutical preparations and substances for the treatment of calcium deficiency; Pharmaceutical preparations and substances being calcium regulators; Pharmaceutical preparations and substances for the treatment of Paget's disease; Phosphates for pharmaceutical purposes; Self-injectors sold filled with pharmaceutical preparations for the treatment of infertility for subcutaneous injection, osteoporosis; Vitamin supplements; mineral supplements; calcium supplements; all the above being for human use and none being for dental use or for use in relation to oral hygiene
Owner
- Theramex HQ UK Limited, Belgravia, London, GB
- Theramex HQ UK Limited, Belgravia, London, GB
- Theramex HQ UK Limited, Belgravia, London, GB
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 21 Sept 2023 — WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
- 20 Sept 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION
- 30 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Aug 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jul 2023 — NON-FINAL ACTION E-MAILED
- 06 Jul 2023 — NON-FINAL ACTION WRITTEN
- 22 Jun 2023 — ASSIGNED TO EXAMINER